Jonathan Canaani

18PUBLICATIONS
11CO-AUTHORS
Haematological tumoursRespiratory diseasesTime series and spatial modellingPsychological methodology, design and analysisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 31, 2023
Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia.

Jonathan Canaani, Avraham Frisch, Daniel A Pollyea

|Mar 11, 2023
The occurrence of thrombosis during intensive chemotherapy treatment for acute myeloid leukemia patients does not impact on long-term survival.

Tamer Hellou, Omri Cohen, Abraham Avigdor

|Sep 21, 2022
Contemporary evaluation of acute myeloid leukemia patients with long-term survival exceeding 5 years.

Gabriel Heering, Maya Sasson, Dan Dominissini

|Jan 28, 2022
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocol.

Danielle Fredman, Yakir Moshe, Ofir Wolach

|Jan 06, 2022
ELN 2017 classification significantly impacts the risk of early death in acute myeloid leukemia patients receiving intensive induction chemotherapy.

Naama Keren-Froim, Gabriel Heering, Gal Sharvit

|Jan 03, 2022
Cytogenetic risk classification maintains its prognostic significance in transplanted FLT3-ITD mutated acute myeloid leukemia patients: On behalf of the acute leukemia working party/European society of blood and marrow transplantation.

Arnon Nagler, Myriam Labopin, Charles Craddock

Pageof 3

Frequent Collaborators

2 joint publications

Yishai Ofran

2 joint publications

Ofir Wolach

2 joint publications

Chezi Ganzel

1 joint publications

Xiao J Huang